Graham; Kenneth S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Graham; Kenneth S..The latest application filed is for "high concentration vegf receptor fusion protein containing formulations".

Company Profile

3.9.13

Graham; Kenneth S. - Pleasant Valley NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Concentration VEGF Receptor Fusion Protein Containing Formulations App 20210353714 - Graham; Kenneth S. ; et al.	2021-11-18
High concentration VEGF receptor fusion protein containing formulations Grant 11,103,552 - Graham , et al. August 31, 2	2021-08-31
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies Grant 11,098,127 - Dix , et al. August 24, 2	2021-08-24
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies App 20210230283 - Dix; Daniel B. ; et al.	2021-07-29
Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab Grant 11,071,780 - Vitti , et al. July 27, 2	2021-07-27
High Concentration Vegf Receptor Fusion Protein Containing Formulations App 20190343918 - Graham; Kenneth S. ; et al.	2019-11-14
Methods And Formulations For Treating Vascular Eye Diseases App 20190117767 - VITTI; Robert L. ; et al.	2019-04-25
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies App 20190002574 - Dix; Daniel B. ; et al.	2019-01-03
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies Grant 10,072,086 - Dix , et al. September 11, 2	2018-09-11
Methods And Formulations For Treating Vascular Eye Diseases App 20170080086 - VITTI; Robert L. ; et al.	2017-03-23
Methods And Formulations For Treating Vascular Eye Diseases App 20160144025 - VITTI; Robert L. ; et al.	2016-05-26
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies App 20160002341 - Dix; Daniel B. ; et al.	2016-01-07
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies Grant 9,173,880 - Dix , et al. November 3, 2	2015-11-03
VEGF Antagonist Formulations for Intravitreal Administration App 20120087929 - FURFINE; Eric ; et al.	2012-04-12
VEGF antagonist formulations for intravitreal administration Grant 8,092,803 - Furfine , et al. January 10, 2	2012-01-10
Vegf Antagonist Formulations For Intravitreal Administration App 20110257601 - FURFINE; Eric ; et al.	2011-10-20
Stabilized Formulations Containing Anti-Interleukin-6 (IL-6) Antibodies App 20110171241 - DIX; Daniel B. ; et al.	2011-07-14
Lyophilized VEGF antagonist formulations for intravitreal administration Grant 7,807,164 - Furfine , et al. October 5, 2	2010-10-05
Lyophilized VEGF Antagonist Formulations for Intravitreal Administration App 20100075903 - FURFINE; Eric ; et al.	2010-03-25
VEGF antagonist formulations suitable for intravitreal administration Grant 7,608,261 - Furfine , et al. October 27, 2	2009-10-27
VEGF antagonist formulations suitable for intravitreal administration App 20070293432 - Furfine; Eric ; et al.	2007-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.